Navigation Links
Nephros Provides Corporate Update
Date:11/20/2008

ated domains in the U.S. and abroad," said Mr. Elgin. "To that end, we will seek to expand our distribution network and leverage strategic relationship opportunities to generate greater access to these markets."

"Nephros's Board of Directors applauds Mr. Elgin's efforts to reduce costs and maximize value for Nephros shareholders. We believe that the aggressive changes that Nephros's new CEO has implemented will help position Nephros for long-term success," said James S. Scibetta, Chairman of Nephros.

About Nephros, Inc.

Nephros, Inc., headquartered in New York, is a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification.

The Nephros hemodiafiltration ("HDF") system is designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized by the irreversible loss of kidney function. The Nephros HDF system removes a range of harmful substances more effectively, and with greater capacity, than existing ESRD treatment methods, particularly with respect to substances known collectively as "middle molecules." These molecules have been found to contribute to such conditions as dialysis-related amyloidosis, carpal tunnel syndrome, degenerative bone disease and, ultimately, mortality in the ESRD patient. Nephros ESRD products are sold and distributed throughout Europe and are currently being used in over fifty clinics in Europe.

The Nephros Dual Stage Ultrafilter (DSU) is the basis for Nephros's line of water filtration products. The patented dual stage cold sterilization ultrafilter has the capability to filter out bacteria and, due to its exceptional filtration levels, filter out many viruses, parasites and biotoxins. The DSU is in pilot-use programs at s
'/>"/>

SOURCE Nephros, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Nephros Receives Non-Compliance Notification from AMEX
2. Nephros Exhibiting at Maryland Ashe Conference July 20th-23rd
3. Nephros Appoints Gerald J. Kochanski as Chief Financial Officer
4. Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results
5. CJPS Enterprises Provides New Strategies To Create Additional Revenues for Companies with Intellectual Property
6. Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility
7. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
8. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
9. New Study Provides Key Findings for Biopharma Product Launch Evaluation
10. ConjuChem Provides Development Update
11. BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... 16, 2014  Vermillion, Inc. (NASDAQ: VRML ... today announced the next step in its expanded strategy ... provider with the naming of current Chief Operating Officer, ... Officer, while current Chairman of the Board and CEO ... Chairman. These changes are effective January 1, 2015. ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... Fortune Magazine has named Neogen Corporation (Nasdaq: ... 100 fastest growing small public companies (FSB 100). , , ... "In good times the FSB 100 constitutes an elite group of ... growth and stock performance over the past three years. But in ...
... , RESTON, Va., July 9 Mirixa Corporation, the ... the hiring of three new members to its growing ... FASCP, Kim Swiger, RPh, and Paul Miller, MS, RPh. ... closely with Mirixa,s pharmacy partners, state and national pharmacy ...
... BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), ... that at ATS Labs, using a Quantitative Disk ... (C.diff) spores, BioNeutral,s Ygiene(TM) Hospital Grade antimicrobial delivered ... Clostridium Difficile, an extremely dangerous and difficult to ...
Cached Biology Technology:Neogen Named to Fortune's List of Fastest Growing Companies 2Mirixa Corporation Announces Key New Hires 2BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase 2BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase 3
(Date:11/21/2014)... 2014 Strict laws against distracted driving and ... North American and European automotive sector towards gesture recognition ... systems that are intuitive and able to retrieve information ... New analysis from Frost & Sullivan,s ... Europe and North ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... --  News Highlights: , ... Partners Data Lake, an agile data and analytics ... allow researcher and clinicians to explore and develop ... of patients , The Partners Data Lake ... Partners system, breaking down physical barriers for collaboration ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... homeland called Hawaiki. Their origins and the existence of ... much speculation. In a new study in the premier ... now provide the first direct evidence for the common ... involving mitochondrial DNA (mtDNA) have been used to try ...
... at the MUHC have made an important discovery that ... estrogen causes growth of breast cancer cells. The research, ... Cliniques de Montreal (IRCM) identifies 153 genes that respond ... used to halt the growth of breast cancer cells. ...
... of a family of mysterious objects called microcompartments that ... The discovery was published Aug. 5 in the journal ... microcompartments are built, and what the pieces look like," ... biochemistry, and a member of the UCLA-DOE Institute of ...
Cached Biology News:Genetic link confirmed between Polynesians and indigenous Taiwanese 2Scientists discover genetic pathway responsible for breast cancer cell growth 2Field tested: Grasslands won't help buffer climate change as carbon dioxide levels rise 2Field tested: Grasslands won't help buffer climate change as carbon dioxide levels rise 3
... Process Control at its Best: ... Real-Time Monitoring, Online Changes & comprehensive ... range of parameters auch as pH, ... are accessible and changeable online. Profiles, ...
... immunological studies, vaccine development, and biosensor ... powerful Paraflo microfluidic on-chip synthesis platform. ... of our comprehensive Epitope Peptide Microarray ... Probe content is completely customer ...
... custom designed to meet your needs. Two ... features per array (2 arrays/1" x 3" ... (1 array/slide). Features ... This extended length delivers higher sensitivity compared ...
... The Agilent Two-Color RNA Spike-In Kit ... specifically anneal only to complementary control probes ... cross-hybridization. The spike-ins serve as a positive ... * NOTE: This kit is a ...
Biology Products: